Lantheus Holdings Inc. (LNTH) PT Raised to $12.00 at RBC Capital Markets
Lantheus Holdings Inc. (NASDAQ:LNTH) had its price objective lifted by RBC Capital Markets from $6.00 to $12.00 in a note issued to investors on Tuesday. The brokerage presently has an “outperform” rating on the stock. RBC Capital Markets’ target price suggests a potential upside of 29.03% from the company’s current price.
Other equities research analysts have also recently issued research reports about the company. Zacks Investment Research upgraded Lantheus Holdings from a “hold” rating to a “buy” rating and set a $9.50 price objective for the company in a report on Tuesday, October 18th. Jefferies Group increased their price objective on Lantheus Holdings from $8.00 to $12.00 and gave the stock a “buy” rating in a report on Monday, August 29th. Finally, Credit Suisse Group AG reiterated a “hold” rating and issued a $9.00 price objective on shares of Lantheus Holdings in a report on Thursday, November 3rd. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $9.96.
Shares of Lantheus Holdings (NASDAQ:LNTH) opened at 9.30 on Tuesday. The stock’s 50 day moving average price is $8.56 and its 200 day moving average price is $5.58. Lantheus Holdings has a 12-month low of $1.76 and a 12-month high of $10.30. The company has a market cap of $282.60 million, a P/E ratio of 10.50 and a beta of 0.48.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in LNTH. Smith Asset Management Group LP purchased a new position in Lantheus Holdings during the third quarter worth approximately $111,000. Engineers Gate Manager LP purchased a new position in Lantheus Holdings during the third quarter worth approximately $120,000. DIAM Co. Ltd. purchased a new position in Lantheus Holdings during the third quarter worth approximately $135,000. Bank of New York Mellon Corp boosted its position in Lantheus Holdings by 45.1% in the third quarter. Bank of New York Mellon Corp now owns 17,071 shares of the company’s stock worth $141,000 after buying an additional 5,305 shares during the last quarter. Finally, Northern Trust Corp boosted its position in Lantheus Holdings by 22.4% in the third quarter. Northern Trust Corp now owns 21,406 shares of the company’s stock worth $177,000 after buying an additional 3,923 shares during the last quarter. Institutional investors own 31.73% of the company’s stock.
About Lantheus Holdings
Lantheus Holdings, Inc develops, manufactures and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The Company’s portfolio of approximately 10 commercial products is spread across a range of imaging modalities.
Receive News & Stock Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related stocks with our FREE daily email newsletter.